Clinical trial
Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer
NCT00006260 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00006260 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer |
| Official title | A Phase II Study Of An OutPatient Three Day VIP Regimen With Oral Mesna For Metastatic Breast Cancer |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, etoposide, ifosfamide, Mesna |
| Enrollment | 36 |
| Start date | May 1, 1997 |
| Primary completion | Jan 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 11, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: